GSK halts camlipixant development for chronic cough after mixed results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/23/2026

1. GOOGL
2. TSLA
3. TXN
4. NOW
5. GOOG
6. CSX
7. KNX
8. AMD
9. IBM
10. LVS

Go back to GSK halts camlipixant development for chronic cough after mixed results

Form 6-K GSK plc For: Jul 17

July 17, 2026 6:50 AM EDT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.... More